Profound Medical
(NASDAQ:PROF)
$4.375
0.295[7.23%]
Last update: 3:14PM
Day Range4.02 - 4.3852 Wk Range3.9 - 11.51Open / Close4.02 / -Float / Outstanding18.9M / 20.9M
Vol / Avg.18.4K / 36.1KMkt Cap91.2MP/E-50d Avg. Price6.77
Div / Yield-Payout Ratio-Total Float18.9MEPS-0.28

Profound Medical Stock (NASDAQ:PROF), Earnings Estimates, EPS, and Revenue

Profound Medical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Aug 4

EPS

$-0.280

Quarterly Revenue

$2M

Annual Revenue (as of Jun 30)

$6.9M

Earnings Recap

Profound Medical (NASDAQ:PROF) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Profound Medical beat estimated earnings by 170.0%, reporting an EPS of $0.28 versus an estimate of $-0.4.

Revenue was down $602 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03 which was followed by a 5.02% increase in the share price the next day.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings History

Analyze the earnings history of Profound Medical using advanced sorting and filters.

Date
time
Quarter
Prior EPS
Est EPS
Actual EPS
EPS Surprise
Prior Rev
Est Rev
Actual Rev
Rev Surprise
Get Alert

Profound Medical Questions & Answers

Q
When is Profound Medical (NASDAQ:PROF) reporting earnings?
A

Profound Medical (PROF) is scheduled to report earnings on November 3, 2022. The last reported earnings were for reported on August 4, 2022 for Q2.

Q
What were the latest earnings per share (EPS) for Profound Medical (NASDAQ:PROF)?
A

The Actual EPS was $-0.43, which missed the estimate of $0.00.

Q
What were Profound Medical’s (NASDAQ:PROF) revenues?
A

The Actual Revenue was $518.5K, which beat the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.